PDB Short entry for 2Q7M HEADER MEMBRANE PROTEIN, LIPID TRANSPORT 07-JUN-07 2Q7M TITLE CRYSTAL STRUCTURE OF HUMAN FLAP WITH MK-591 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: FLAP, MK-886-BINDING PROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALOX5AP, FLAP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS MAPEG, MEMBRANE PROTEIN, FLAP, LIPID TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR A.D.FERGUSON REVDAT 4 21-FEB-24 2Q7M 1 REMARK REVDAT 3 20-OCT-21 2Q7M 1 REMARK SEQADV REVDAT 2 24-FEB-09 2Q7M 1 VERSN REVDAT 1 21-AUG-07 2Q7M 0 JRNL AUTH A.D.FERGUSON,B.M.MCKEEVER,S.XU,D.WISNIEWSKI,D.K.MILLER, JRNL AUTH 2 T.T.YAMIN,R.H.SPENCER,L.CHU,F.UJJAINWALLA,B.R.CUNNINGHAM, JRNL AUTH 3 J.F.EVANS,J.W.BECKER JRNL TITL CRYSTAL STRUCTURE OF INHIBITOR-BOUND HUMAN JRNL TITL 2 5-LIPOXYGENASE-ACTIVATING PROTEIN. JRNL REF SCIENCE V. 317 510 2007 JRNL REFN ISSN 0036-8075 JRNL PMID 17600184 JRNL DOI 10.1126/SCIENCE.1144346 REMARK 2 REMARK 2 RESOLUTION. 4.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 1.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 16647 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.244 REMARK 3 R VALUE (WORKING SET) : 0.242 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 843 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 4.25 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 4.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.30 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2645 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2875 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2517 REMARK 3 BIN R VALUE (WORKING SET) : 0.2833 REMARK 3 BIN FREE R VALUE : 0.3639 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.84 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 128 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6987 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 246 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 164.4 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 191.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.59548 REMARK 3 B22 (A**2) : -4.59548 REMARK 3 B33 (A**2) : 9.19097 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7439 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 10104 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 1350 ; 0.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 210 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 1090 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 7439 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 739 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.91 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q7M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000043250. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16875 REMARK 200 RESOLUTION RANGE HIGH (A) : 4.250 REMARK 200 RESOLUTION RANGE LOW (A) : 38.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 4.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.51 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 9.60 REMARK 200 R MERGE FOR SHELL (I) : 0.55500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.570 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER-TNT 1.9.3 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 76.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG4000, 0.32 LICL2, 1MM TCEP , PH REMARK 280 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 90.30000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 90.30000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 90.30000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 90.30000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 90.30000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 90.30000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 90.30000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 90.30000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A TRIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8710 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8850 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 140 REMARK 465 SER A 141 REMARK 465 ASP A 142 REMARK 465 PHE A 143 REMARK 465 GLU A 144 REMARK 465 ASN A 145 REMARK 465 TYR A 146 REMARK 465 ILE A 147 REMARK 465 ALA A 148 REMARK 465 THR A 149 REMARK 465 ILE A 150 REMARK 465 SER A 151 REMARK 465 THR A 152 REMARK 465 THR A 153 REMARK 465 ILE A 154 REMARK 465 SER A 155 REMARK 465 PRO A 156 REMARK 465 LEU A 157 REMARK 465 LEU A 158 REMARK 465 LEU A 159 REMARK 465 ILE A 160 REMARK 465 PRO A 161 REMARK 465 THR B 149 REMARK 465 ILE B 150 REMARK 465 SER B 151 REMARK 465 THR B 152 REMARK 465 THR B 153 REMARK 465 ILE B 154 REMARK 465 SER B 155 REMARK 465 PRO B 156 REMARK 465 LEU B 157 REMARK 465 LEU B 158 REMARK 465 LEU B 159 REMARK 465 ILE B 160 REMARK 465 PRO B 161 REMARK 465 ILE C 150 REMARK 465 SER C 151 REMARK 465 THR C 152 REMARK 465 THR C 153 REMARK 465 ILE C 154 REMARK 465 SER C 155 REMARK 465 PRO C 156 REMARK 465 LEU C 157 REMARK 465 LEU C 158 REMARK 465 LEU C 159 REMARK 465 ILE C 160 REMARK 465 PRO C 161 REMARK 465 ALA D 148 REMARK 465 THR D 149 REMARK 465 ILE D 150 REMARK 465 SER D 151 REMARK 465 THR D 152 REMARK 465 THR D 153 REMARK 465 ILE D 154 REMARK 465 SER D 155 REMARK 465 PRO D 156 REMARK 465 LEU D 157 REMARK 465 LEU D 158 REMARK 465 LEU D 159 REMARK 465 ILE D 160 REMARK 465 PRO D 161 REMARK 465 SER E 141 REMARK 465 ASP E 142 REMARK 465 PHE E 143 REMARK 465 GLU E 144 REMARK 465 ASN E 145 REMARK 465 TYR E 146 REMARK 465 ILE E 147 REMARK 465 ALA E 148 REMARK 465 THR E 149 REMARK 465 ILE E 150 REMARK 465 SER E 151 REMARK 465 THR E 152 REMARK 465 THR E 153 REMARK 465 ILE E 154 REMARK 465 SER E 155 REMARK 465 PRO E 156 REMARK 465 LEU E 157 REMARK 465 LEU E 158 REMARK 465 LEU E 159 REMARK 465 ILE E 160 REMARK 465 PRO E 161 REMARK 465 ILE F 150 REMARK 465 SER F 151 REMARK 465 THR F 152 REMARK 465 THR F 153 REMARK 465 ILE F 154 REMARK 465 SER F 155 REMARK 465 PRO F 156 REMARK 465 LEU F 157 REMARK 465 LEU F 158 REMARK 465 LEU F 159 REMARK 465 ILE F 160 REMARK 465 PRO F 161 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 110 C - N - CD ANGL. DEV. = -23.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 2 107.82 -53.80 REMARK 500 ASN A 8 33.35 -82.82 REMARK 500 VAL A 9 -17.29 -158.62 REMARK 500 ASN A 38 167.38 -42.36 REMARK 500 PHE A 42 74.31 -113.66 REMARK 500 THR A 45 101.17 -39.43 REMARK 500 THR A 47 135.24 -37.78 REMARK 500 GLN A 58 25.91 -66.75 REMARK 500 ALA A 69 -73.93 -53.46 REMARK 500 LEU A 77 5.23 -61.98 REMARK 500 CYS A 78 128.59 170.61 REMARK 500 SER A 79 113.03 23.65 REMARK 500 TYR A 101 33.02 -83.12 REMARK 500 LEU A 102 -91.69 -137.23 REMARK 500 GLU A 104 125.36 167.01 REMARK 500 ARG A 105 -38.24 58.47 REMARK 500 GLN A 107 75.10 -59.89 REMARK 500 ALA A 128 -78.27 -69.86 REMARK 500 ASP B 2 106.48 -56.45 REMARK 500 GLN B 3 -33.87 -38.54 REMARK 500 ASN B 8 33.54 -82.69 REMARK 500 VAL B 9 -23.14 -153.26 REMARK 500 VAL B 10 -36.16 -38.82 REMARK 500 THR B 36 6.49 -49.96 REMARK 500 GLN B 37 -145.21 -166.12 REMARK 500 ASN B 38 26.18 -73.98 REMARK 500 SER B 41 9.74 137.25 REMARK 500 THR B 45 57.64 177.06 REMARK 500 THR B 47 142.04 113.43 REMARK 500 LEU B 48 -54.08 30.47 REMARK 500 GLN B 58 21.32 -65.83 REMARK 500 ALA B 69 -75.68 -49.98 REMARK 500 LEU B 77 9.61 -64.67 REMARK 500 CYS B 78 130.33 171.14 REMARK 500 SER B 79 116.25 13.80 REMARK 500 TYR B 101 30.36 -81.85 REMARK 500 ARG B 105 -144.19 81.65 REMARK 500 THR B 106 -172.36 40.31 REMARK 500 SER B 108 83.52 -57.09 REMARK 500 PRO B 110 37.55 -56.79 REMARK 500 PHE B 114 -108.47 -143.55 REMARK 500 ALA B 128 -74.77 -69.80 REMARK 500 PHE B 138 -86.78 -98.58 REMARK 500 PHE B 139 3.22 -61.01 REMARK 500 SER B 141 -108.59 -81.04 REMARK 500 ASP B 142 -95.60 26.65 REMARK 500 PHE B 143 24.55 24.97 REMARK 500 ASN B 145 60.88 -114.08 REMARK 500 TYR B 146 69.06 -63.79 REMARK 500 ASP C 2 105.80 -51.91 REMARK 500 REMARK 500 THIS ENTRY HAS 148 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CS C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CS A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CS A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CS D 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CS E 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CS E 506 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q7R RELATED DB: PDB DBREF 2Q7M A 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7M B 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7M C 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7M D 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7M E 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7M F 1 161 UNP P20292 AL5AP_HUMAN 1 161 SEQADV 2Q7M ALA A 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7M ALA B 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7M ALA C 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7M ALA D 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7M ALA E 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7M ALA F 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQRES 1 A 161 MET ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 A 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 A 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 A 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 A 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 A 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 A 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET TYR LEU SEQRES 8 A 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 A 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 A 161 ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA GLY ILE SEQRES 11 A 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 A 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 A 161 LEU LEU LEU ILE PRO SEQRES 1 B 161 MET ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 B 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 B 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 B 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 B 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 B 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 B 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET TYR LEU SEQRES 8 B 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 B 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 B 161 ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA GLY ILE SEQRES 11 B 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 B 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 B 161 LEU LEU LEU ILE PRO SEQRES 1 C 161 MET ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 C 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 C 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 C 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 C 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 C 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 C 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET TYR LEU SEQRES 8 C 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 C 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 C 161 ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA GLY ILE SEQRES 11 C 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 C 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 C 161 LEU LEU LEU ILE PRO SEQRES 1 D 161 MET ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 D 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 D 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 D 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 D 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 D 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 D 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET TYR LEU SEQRES 8 D 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 D 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 D 161 ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA GLY ILE SEQRES 11 D 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 D 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 D 161 LEU LEU LEU ILE PRO SEQRES 1 E 161 MET ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 E 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 E 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 E 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 E 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 E 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 E 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET TYR LEU SEQRES 8 E 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 E 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 E 161 ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA GLY ILE SEQRES 11 E 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 E 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 E 161 LEU LEU LEU ILE PRO SEQRES 1 F 161 MET ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 F 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 F 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 F 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 F 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 F 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 F 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET TYR LEU SEQRES 8 F 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 F 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 F 161 ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA GLY ILE SEQRES 11 F 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 F 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 F 161 LEU LEU LEU ILE PRO HET 2CS A 502 41 HET 2CS A 503 41 HET 2CS C 501 41 HET 2CS D 504 41 HET 2CS E 505 41 HET 2CS E 506 41 HETNAM 2CS 3-[3-(TERT-BUTYLTHIO)-1-(4-CHLOROBENZYL)-5-(QUINOLIN-2- HETNAM 2 2CS YLMETHOXY)-1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID FORMUL 7 2CS 6(C34 H35 CL N2 O3 S) HELIX 1 1 ASP A 2 ASN A 8 1 7 HELIX 2 2 VAL A 9 GLN A 37 1 29 HELIX 3 3 THR A 47 LEU A 77 1 31 HELIX 4 4 SER A 79 GLY A 100 1 22 HELIX 5 5 GLY A 115 PHE A 139 1 25 HELIX 6 6 ASP B 2 THR B 36 1 35 HELIX 7 7 THR B 47 LEU B 77 1 31 HELIX 8 8 SER B 79 GLY B 100 1 22 HELIX 9 9 LYS B 116 PHE B 143 1 28 HELIX 10 10 ASP C 2 ASN C 8 1 7 HELIX 11 11 VAL C 9 GLN C 37 1 29 HELIX 12 12 THR C 47 LEU C 77 1 31 HELIX 13 13 GLN C 80 GLY C 100 1 21 HELIX 14 14 GLY C 115 PHE C 139 1 25 HELIX 15 15 ASP D 2 ASN D 8 1 7 HELIX 16 16 VAL D 9 THR D 36 1 28 HELIX 17 17 THR D 47 LEU D 77 1 31 HELIX 18 18 GLN D 80 TYR D 101 1 22 HELIX 19 19 GLY D 115 PHE D 139 1 25 HELIX 20 20 GLY D 140 PHE D 143 5 4 HELIX 21 21 ASP E 2 ASN E 8 1 7 HELIX 22 22 VAL E 9 THR E 36 1 28 HELIX 23 23 THR E 47 LEU E 77 1 31 HELIX 24 24 GLN E 80 GLY E 103 1 24 HELIX 25 25 GLY E 115 PHE E 139 1 25 HELIX 26 26 ASP F 2 GLN F 37 1 36 HELIX 27 27 THR F 47 LEU F 77 1 31 HELIX 28 28 GLN F 80 GLY F 100 1 21 HELIX 29 29 ARG F 117 PHE F 139 1 23 SITE 1 AC1 11 ASP B 62 ALA B 63 LYS B 116 ILE B 119 SITE 2 AC1 11 LEU B 120 PHE B 123 VAL C 21 ASN C 23 SITE 3 AC1 11 GLY C 24 PHE C 25 ALA C 27 SITE 1 AC2 11 VAL A 21 ASN A 23 GLY A 24 PHE A 25 SITE 2 AC2 11 ALA A 27 HIS A 28 ASP C 62 ALA C 63 SITE 3 AC2 11 ILE C 113 ILE C 119 LEU C 120 SITE 1 AC3 14 ASP A 62 ALA A 63 TYR A 112 ILE A 113 SITE 2 AC3 14 LYS A 116 ILE A 119 LEU A 120 PHE A 123 SITE 3 AC3 14 VAL B 21 ASN B 23 GLY B 24 PHE B 25 SITE 4 AC3 14 ALA B 27 HIS B 28 SITE 1 AC4 11 VAL D 21 ASN D 23 GLY D 24 PHE D 25 SITE 2 AC4 11 ALA D 27 ASN D 57 ASP F 62 ALA F 63 SITE 3 AC4 11 LYS F 116 ILE F 119 LEU F 120 SITE 1 AC5 13 ASP D 62 ALA D 63 LYS D 116 ILE D 119 SITE 2 AC5 13 LEU D 120 PHE D 123 VAL E 21 ASN E 23 SITE 3 AC5 13 GLY E 24 PHE E 25 ALA E 27 HIS E 28 SITE 4 AC5 13 VAL E 61 SITE 1 AC6 12 ASP E 62 ALA E 63 ILE E 113 LYS E 116 SITE 2 AC6 12 ILE E 119 LEU E 120 PHE E 123 VAL F 21 SITE 3 AC6 12 ASN F 23 GLY F 24 PHE F 25 ALA F 27 CRYST1 180.600 180.600 140.570 90.00 90.00 90.00 P 4 21 2 48 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005537 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005537 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007114 0.00000